LFVN — Lifevantage Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual income statement for Lifevantage, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	220	206	213	200	229
Cost of Revenue
Gross Profit	182	168	170	159	184
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses	203	201	209	196	216
Operating Profit	17.6	5.37	4.26	4.33	12.2
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17.2	4.69	4	4.35	12.2
Provision for Income Taxes
Net Income After Taxes	12.9	3.12	2.54	2.94	9.8
Net Income Before Extraordinary Items
Net Income	12.9	3.12	2.54	2.94	9.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12.9	3.12	2.54	2.94	9.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.945	0.351	0.222	0.226	0.755
Dividends per Share
Special Dividends per Share